How genomic studies have improved our understanding of the mechanisms of transcriptional regulation by NR5A nuclear receptors

Molecular and Cellular Endocrinology

Volumn 408, Issue , 2015, Pages 138-144

  Ruggiero, Carmen ^a,b,c   Doghman, Mabrouka ^a,b,c   Lalli, Enzo ^a,b,c  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b Laboratoire International Associé   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

Adrenal cortex; Endocrine cancers; Nuclear receptors; Transcription factors

Indexed keywords

BETA CATENIN; LIVER RECEPTOR HOMOLOG 1; STEROIDOGENIC FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN; CELL RECEPTOR;

BINDING SITE; BREAST CANCER; CELL COUNT; DNA BINDING; DOWN REGULATION; ENDOCRINE TUMOR; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION; H295R CELL; HUMAN; MCF 7 CELL LINE; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; STEROIDOGENESIS; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; UPREGULATION; Y1 CELL; ANIMAL; ANTIBODY SPECIFICITY; BIOLOGICAL MODEL; GENETIC TRANSCRIPTION; GENETICS; GENOMICS; METABOLISM;

ANIMALS; GENE EXPRESSION REGULATION; GENOMICS; HUMANS; MODELS, GENETIC; ORGAN SPECIFICITY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION, GENETIC;

EID: 84926684044     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.10.022     Document Type: Review

References (58)

1. Achermann J.C., Ozisik G., Ito M., Orun U.A., Harmanci K., Gurakan B., et al. Gonadal determination and adrenal development are regulated by the orphan nuclear receptor Steroidogenic factor- 1, in a dose-dependent manner. J. Clin. Endocrinol. Metab 2002, 87:1829-1833.
2. Annicotte J.S., Chavey C., Servant N., Teyssier J., Bardin A., Licznar A., et al. The nuclear receptor liver receptor homolog-1 is an estrogen receptor target gene. Oncogene 2005, 24:8167-8175.
3. Baba T., Otake H., Sato T., Miyabayashi K., Shishido Y., Wang C.Y., et al. Glycolytic genes are targets of the nuclear receptor Ad4BP/SF-1. Nat. Commun 2014, 5:3634.
4. Bassett M.H., Zhang Y., Clyne C., White P.C., Rainey W.E. Differential regulation of aldosterone synthase and 11β-hydroxylase transcription by Steroidogenic Factor-1. J. Mol. Endocrinol 2002, 28:125-135.
5. Benod C., Vinogradova M.V., Jouravel N., Kim G.E., Fletterick R.J., Sablin E.P. Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferation. Proc. Natl. Acad. Sci. USA 2011, 108:16927-16931.
6. Benod C., Carlsson J., Uthayaruban R., Hwang P., Irwin J.J., Doak A.K., et al. Structure-based discovery of antagonists of nuclear receptor LRH-1. J. Biol. Chem 2013, 288:19830-19844.
7. Beuschlein F., Mutch C., Bavers D.L., Ulrich-Lai Y.M., Engeland W.C., Keegan C., et al. Steroidogenic factor-1 is essential for compensatory adrenal growth following unilateral adrenalectomy. Endocrinology 2002, 143:3122-3135.
8. Bianco S., Brunelle M., Jangal M., Magnani L., Gévry N. LRH-1 governs vital transcriptional programs in endocrine-sensitive and -resistant breast cancer cells. Cancer Res 2014, 74:2015-2025.
9. Bland M.L., Jamieson C.A., Akana S.F., Bornstein S.R., Eisenhofer G., Dallman M.F., et al. Haploinsufficiency of Steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response. Proc. Natl. Acad. Sci. USA 2000, 97:14488-14493.
10. 1 cyclin-mediated cell proliferation. Mol. Cell 2004, 15:499-509.
11. Charest-Marcotte A., Dufour C.R., Wilson B.J., Tremblay A.M., Eichner L.J., Arlow D.H., et al. The homeobox protein Prox1 is a negative modulator of ERRalpha/PGC-1alpha bioenergetic functions. Genes Dev 2010, 24:537-542.
12. Chong H.K., Infante A.M., Seo Y.-K., Jeon T.I., Zhang Y., Edwards P.A., et al. Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1. Nucleic Acids Res 2010, 38:6007-6017.
13. Chong H.K., Biensinger J., Seo Y.-K., Xie X., Osborne T.F. Genome-wide analysis of hepatic LRH-1 reveals a promoter binding preference and suggests a role in regulating genes of lipid metabolism in concert with FXR. BMC Genomics 2012, 13:51.
14. Chong J.A., Tapia-Ramírez J., Kim S., Toledo-Aral J.J., Zheng Y., Boutros M.C., et al. REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons. Cell 1995, 80:949-957.
15. Clyne C.D., Speed C.J., Zhou J., Simpson E.R. Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes. J. Biol. Chem 2002, 277:20591-20597.
16. Doghman M., Lalli E. A matter of dosage: SF-1 in adrenocortical development and cancer. Ann. Endocrinol. (Paris) 2009, 70:148-152.
17. Doghman M., Karpova T., Rodrigues G.A., Arhatte M., De Moura J., Cavalli L.R., et al. Increased Steroidogenic Factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol. Endocrinol 2007, 21:2968-2987.
18. Doghman M., Arhatte M., Thibout H., Rodrigues G., De Moura J., Grosso S., et al. Nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors. J. Clin. Endocrinol. Metab 2007, 92:3253-3260.
19. Doghman M., Cazareth J., Douguet D., Madoux F., Hodder P., Lalli E. Inhibition of adrenocortical carcinoma cell proliferation by SF-1 inverse agonists. J. Clin. Endocrinol. Metab 2009, 94:2178-2183.
20. Doghman M., Figueiredo B.C., Volante M., Papotti M., Lalli E. Integrative analysis of SF-1 transcription factor dosage impact on genome-wide binding and gene expression regulation. Nucleic Acids Res 2013, 41:8896-8907.
21. Duggavathi R., Volle D.H., Mataki C., Antal M.C., Messaddeq N., Auwerx J., et al. Liver receptor homolog 1 is essential for ovulation. Genes Dev 2008, 22:1871-1876.
22. Ehrlund A., Holter Anthonisen E., Gustafsson N., Venteclef N., Robertson Remen K., Damdimopoulos A.E., et al. The E3 ubiquitin ligase RNF31 cooperates with DAX-1 in transcriptional repression of steroidogenesis. Mol. Cell. Biol 2009, 29:2230-2242.
23. Ehrlund A., Jonsson P., Vedin L.L., Williams C., Gustafsson J.Å., Treuter E. Knockdown of SF-1 and RNF31 affects components of steroidogenesis, TGFβ, and Wnt/β-catenin signaling in adrenocortical carcinoma cells. PLoS ONE 2012, 7:e32080.
24. El Wakil A., Lalli E. The Wnt/beta-catenin pathway in adrenocortical development and cancer. Mol. Cell. Endocrinol 2011, 332:32-37.
25. Feng D., Liu T., Sun Z., Bugge A., Mullican S.E., Alenghat T., et al. A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science 2011, 331:1315-1319.
26. Ferraz-de-Souza B., Lin L., Shah S., Jina N., Hubank M., Dattani M.T., et al. ChIP-on-chip analysis reveals angiopoietin 2 (Ang2, ANGPT2) as a novel target of Steroidogenic Factor-1 (SF-1, NR5A1) in the human adrenal gland. FASEB J. 2011, 25:1166-1175.
27. Ferraz-de-Souza B., Hudson-Davies R.E., Lin L., Parnaik R., Hubank M., Dattani M.T., et al. Sterol-O-Acyltransferase 1 (SOAT1, ACAT) is a novel target of Steroidogenic Factor-1 (SF-1, NR5A1, Ad4BP) in the human adrenal. J. Clin. Endocrinol. Metab 2011, 96:E663-E668.
28. Guo G., Smith A. A genome-wide screen in EpiSC identifies Nr5a nuclear receptors as potent inducers of ground state pluripotency. Development 2010, 137:3185-3192.
29. Heng J.-C.D., Feng B., Han J., Jiang J., Kraus P., Ng J.-H., et al. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell 2010, 6:167-174.
30. Holmstrom S.R., Deering T., Swift G.H., Poelwijk F.J., Mangelsdorf D.J., Kliewer S.A., et al. LRH-1 and PTF1-L coregulate an exocrine pancreas-specific transcriptional network for digestive function. Genes Dev 2011, 25:1674-1679.
31. Johnsen I.K., Beuschlein F. Role of bone morphogenetic proteins in adrenal physiology and disease. J. Mol. Endocrinol 2010, 44:203-211.
32. Lai C.F., Flach K.D., Alexi X., Fox S.P., Ottaviani S., Thiruchelvam P.T., et al. Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells. Nucleic Acids Res 2013, 41:10228-10240.
33. Lalli E., Doghman M., Latre de Late P., El Wakil A., Mus-Veteau I. Beyond steroidogenesis: novel target genes for SF-1 discovered by genomics. Mol. Cell. Endocrinol 2013, 371:154-159.
34. Lee M., Marinoni I., Irmler M., Psaras T., Honegger J.B., Beschorner R., et al. Transcriptome analysis of MENX-associated rat pituitary adenomas identifies novel molecular mechanisms involved in the pathogenesis of human pituitary gonadotroph adenoma. Acta Neuropathol 2013, 126:137-150.
35. Lee Y.K., Moore D.D. Liver receptor homolog-1, an emerging metabolic modulator. Front. Biosci 2008, 13:5950-5958.
36. Lewis S.R., Hedman C.J., Ziegler T., Ricke W.A., Jorgensen J.S. Steroidogenic factor 1 promotes aggressive growth of castration-resistant prostate cancer cells by stimulating steroid synthesis and cell proliferation. Endocrinology 2014, 155:358-369.
37. Lin L., Philibert P., Ferraz-de-Souza B., Kelberman D., Homfray T., Albanese A., et al. Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function. J. Clin. Endocrinol. Metab 2007, 92:991-999.
38. Lu T.T., Makishima M., Repa J.J., Schoonjans K., Kerr T.A., Auwerx J., et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell 2000, 6:507-515.
39. Luo X., Ikeda Y., Parker K.L. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994, 77:481-490.
40. Mataki C., Magnier B.C., Houten S.M., Annicotte J.S., Argmann C., Thomas C., et al. Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1. Mol. Cell. Biol 2007, 27:8330-8339.
41. McLean C.Y., Bristor D., Hiller M., Clarke S.L., Schaar B.T., Lowe C.B., et al. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol 2010, 28:495-501.
42. Nuclear Receptors Nomenclature Committee A unified nomenclature system for the nuclear receptor superfamily. Cell 1999, 97:161-163.
43. Oosterveer M.H., Mataki C., Yamamoto H., Harach T., Moullan N., van Dijk T.H., et al. LRH-1-dependent glucose sensing determines intermediary metabolism in liver. J. Clin. Invest 2012, 122:2817-2826.
44. Pare J.F., Malenfant D., Courtemanche C., Jacob-Wagner M., Roy S., Allard D., et al. The fetoprotein transcription factor (FTF) gene is essential to embryogenesis and cholesterol homeostasis and is regulated by a DR4 element. J. Biol. Chem 2004, 279:21206-21216.
45. Parker K.L., Schimmer B.P. Steroidogenic Factor 1: a key determinant of endocrine development and function. Endocr. Rev 1997, 18:361-377.
46. Petersen G.M., Amundadottir L., Fuchs C.S., Kraft P., Stolzenberg-Solomon R.Z., Jacobs K.B., et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat. Genet 2010, 42:224-228.
47. Pianovski M.A., Cavalli L.R., Figueiredo B.C., Santos S.C., Doghman M., Ribeiro R.C., et al. SF-1 overexpression in childhood adrenocortical tumours. Eur. J. Cancer 2006, 42:1040-1043.
48. Rui X., Tsao J., Scheys J.O., Hammer G.D., Schimmer B.P. Contributions of Specificity Protein-1 and Steroidogenic Factor 1 to Adcy4 expression in Y1 mouse adrenal cells. Endocrinology 2008, 147:2357-2367.
49. Sbiera S., Schmull S., Assié G., Voelker H.-U., Kraus L., Beyer M., et al. High diagnostic and prognostic value of Steroidogenic Factor-1 expression in adrenal tumors. J. Clin. Endocrinol. Metab 2010, 95:E161-E171.
50. Schimmer B.P., Tsao J., Cordova M., Mostafavi S., Morris Q., Scheys J.O. Contributions of Steroidogenic Factor-1 to the transcription landscape of Y1 mouse adrenocortical tumor cells. Mol. Cell. Endocrinol 2011, 336:85-91.
51. Schoenherr C.J., Anderson D.J. The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes. Science 1995, 267:1360-1363.
52. Schoonjans K., Dubuquoy L., Mebis J., Fayard E., Wendling O., Haby C., et al. Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:2058-2062.
53. Thiruchelvam P.T., Lai C.F., Hua H., Thomas R.S., Hurtado A., Hudson W., et al. The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells. Breast Cancer Res. Treat 2011, 127:385-396.
54. Williams T.A., Monticone S., Crudo V., Warth R., Veglio F., Mulatero P. Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis. Hypertension 2012, 59:833-839.
55. Wilson T.E., Fahrer T.J., Millbrandt J. The orphan receptors NGFI-B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction. Mol. Cell. Biol 1993, 13:5794-5804.
56. Ye P., Nakamura Y., Lalli E., Rainey W. Differential effects of high and low Steroidogenic Factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells. Endocrinology 2009, 150:1303-1309.
57. Zhang C., Large M.J., Duggavathi R., DeMayo F.J., Lydon J.P., Schoonjans K., et al. Liver receptor homolog-1 is essential for pregnancy. Nat. Med 2013, 19:1061-1066.
58. Zhou J., Suzuki T., Kovacic A., Saito R., Miki Y., Ishida T., et al. Interactions between prostaglandin E(2), liver receptor homologue-1, and aromatase in breast cancer. Cancer Res 2005, 65:657-663.